{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:55:52Z","timestamp":1789977352953,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10096-016-2834-2","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T06:59:34Z","timestamp":1479106774000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine"],"prefix":"10.1007","volume":"36","author":[{"given":"L.","family":"Georgalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mozalevskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Mart\u00ednez de Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Garrido-Estepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"key":"2834_CR1","volume-title":"Control of communicable diseases manual","author":"DL Heymann","year":"2008","unstructured":"Heymann DL (2008) Control of communicable diseases manual, 19th edn. American Public Health Association, Washington, DC","edition":"19"},{"key":"2834_CR2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N et al (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893\u2013902","journal-title":"Lancet"},{"key":"2834_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","volume":"67","author":"T Welte","year":"2012","unstructured":"Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71\u201379","journal-title":"Thorax"},{"key":"2834_CR4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","volume":"68","author":"A Torres","year":"2013","unstructured":"Torres A, Peetermans WE, Viegi G, Blasi F (2013) Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax 68:1057\u20131065","journal-title":"Thorax"},{"key":"2834_CR5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s12879-016-1783-9","volume":"16","author":"CE Vissink","year":"2016","unstructured":"Vissink CE, Huijts SM, de Wit GA, Bonten MJM, Mangen M-JJ (2016) Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study. BMC Infect Dis 16:466","journal-title":"BMC Infect Dis"},{"key":"2834_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","volume":"31","author":"SP Fitzwater","year":"2012","unstructured":"Fitzwater SP, Chandran A, Santosham M, Johnson HL (2012) The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 31:501\u2013508","journal-title":"Pediatr Infect Dis J"},{"key":"2834_CR7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","volume":"47","author":"A Fenoll","year":"2009","unstructured":"Fenoll A, Granizo JJ, Aguilar L, Gim\u00e9nez MJ, Aragoneses-Fenoll L, Hanquet G et al (2009) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47:1012\u20131020","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2834_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijantimicag.2012.03.001","volume":"40","author":"A Fenoll","year":"2012","unstructured":"Fenoll A, Aguilar L, Gim\u00e9nez M-J, Vicioso M-D, Robledo O, Granizo J-J et al (2012) Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000\u2013May 2001) and 10 years after (May 2010\u2013May 2011) introduction of conjugate vaccines for child immunisation in Spain. Int J Antimicrob Agents 40(1):18\u201323","journal-title":"Int J Antimicrob Agents"},{"key":"2834_CR9","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","volume":"14","author":"DJ Isaacman","year":"2010","unstructured":"Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14:e197\u2013e209","journal-title":"Int J Infect Dis"},{"key":"2834_CR10","doi-asserted-by":"crossref","first-page":"44.e1","DOI":"10.1016\/j.anpedi.2014.10.019","volume":"82","author":"D Moreno-P\u00e9rez","year":"2015","unstructured":"Moreno-P\u00e9rez D, \u00c1lvarez Garc\u00eda FJ, Ar\u00edstegui Fern\u00e1ndez J, Cilleruelo Ortega MJ, Corretger Rauet JM, Garc\u00eda S\u00e1nchez N et al (2015) Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations. An Pediatr (Barc) 82:44.e1-44.e12","journal-title":"An Pediatr (Barc)"},{"key":"2834_CR11","doi-asserted-by":"crossref","first-page":"20922","DOI":"10.2807\/1560-7917.ES2014.19.40.20922","volume":"19","author":"MA Gutierrez Rodriguez","year":"2014","unstructured":"Gutierrez Rodriguez MA, Ordobas Gavin MA, Garcia-Comas L, Sanz Moreno JC, Cordoba Deorador E, Lasheras Carbajo MD et al (2014) Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008\u20132011. Euro Surveill 19:20922","journal-title":"Euro Surveill"},{"key":"2834_CR12","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/INF.0b013e31827e8594","volume":"32","author":"J Picazo","year":"2013","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Garc\u00eda-de-Miguel M-J, Hern\u00e1ndez-Sampelayo T et al (2013) Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011. Pediatr Infect Dis J 32:656\u2013661","journal-title":"Pediatr Infect Dis J"},{"key":"2834_CR13","unstructured":"Xunta de Galicia (2013) La vacunaci\u00f3n infantil con vacuna conjugada trecevalente: Dos a\u00f1os de estudio piloto [13 valent conjugated vaccine infant vaccination: two years of pilot study]. Bolet\u00edn Epidemiol\u00f3xico de Galicia 2013 vol. XXV(3):1\u201315. Galician. Available online at: http:\/\/www.sergas.es\/gal\/documentacionTecnica\/docs\/SaudePublica\/begs\/BEG_XXV-3.pdf"},{"key":"2834_CR14","doi-asserted-by":"crossref","first-page":"e0151125","DOI":"10.1371\/journal.pone.0151125","volume":"11","author":"E Amo Del","year":"2016","unstructured":"Del Amo E, Esteva C, Hernandez-Bou S, Galles C, Navarro M, Sauca G et al (2016) Serotypes and clonal diversity of Streptococcus pneumoniae causing invasive disease in the era of PCV13 in Catalonia, Spain. PLoS One 11:e0151125","journal-title":"PLoS One"},{"issue":"22","key":"2834_CR15","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.vaccine.2014.03.054","volume":"32","author":"M Guevara","year":"2014","unstructured":"Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A et al (2014) Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001\u20132013. Vaccine 32(22):2553\u20132562","journal-title":"Vaccine"},{"key":"2834_CR16","unstructured":"Comisi\u00f3n de Salud P\u00fablica del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad. Grupo de trabajo vacunaci\u00f3n frente a neumococo en grupos de riesgo 2015 de la Ponencia de Programas y Registro de Vacunaciones (2015) Vacunaci\u00f3n frente a neumococo en grupos de riesgo [Vaccination against pneumococcal disease in high-risk groups. Ministry of Health, Social Services and Equality]. Spanish. Available online at: http:\/\/www.msssi.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/docs\/Neumococo_Gruposriesgo.pdf"},{"key":"2834_CR17","unstructured":"Ministerio de Sanidad, Pol\u00edtica Social e Igualdad (2012) Clasificaci\u00f3n Internacional de Enfermedades, 9a Revisi\u00f3n Modificaci\u00f3n Cl\u00ednica. [International Classification of Diseases, 9th Revision Clinical Modification. Ministry of Health, Social Services and Equality]. 8th edition"},{"key":"2834_CR18","doi-asserted-by":"crossref","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","volume":"10","author":"DR Feikin","year":"2013","unstructured":"Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T et al (2013) Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 10:e1001517","journal-title":"PLoS Med"},{"key":"2834_CR19","unstructured":"Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III. Red Nacional de Vigilancia Epidemiol\u00f3gica (2013) Protocolos de enfermedades de declaraci\u00f3n obligatoria. [Protocols for diseases with mandatory notification. National Center for Epidemiology. Instituto de Salud Carlos III. Spain]. Spanish. Available online at: http:\/\/gesdoc.isciii.es\/gesdoccontroller?action=download&id=08\/07\/2015-28724e36ba"},{"issue":"3","key":"2834_CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2010.11.025","volume":"29","author":"R Gil-Prieto","year":"2011","unstructured":"Gil-Prieto R, Garc\u00eda-Garc\u00eda L, Alvaro-Meca A, M\u00e9ndez C, Garc\u00eda A, de Miguel AG (2011) The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003\u20132007). Vaccine 29(3):412\u2013416","journal-title":"Vaccine"},{"key":"2834_CR21","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","volume":"193","author":"LL Hammitt","year":"2006","unstructured":"Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A et al (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 193:1487\u20131494","journal-title":"J Infect Dis"},{"key":"2834_CR22","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","volume":"31","author":"LA Jackson","year":"2013","unstructured":"Jackson LA, Gurtman A, van Cleeff M, Jansen KU, Jayawardene D, Devlin C et al (2013) Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 31:3577\u20133584","journal-title":"Vaccine"},{"key":"2834_CR23","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","volume":"33","author":"RA Gladstone","year":"2015","unstructured":"Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW et al (2015) Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction. Vaccine 33:2015\u20132021","journal-title":"Vaccine"},{"key":"2834_CR24","doi-asserted-by":"crossref","first-page":"e00545-16","DOI":"10.1128\/mBio.00545-16","volume":"7","author":"LS McDaniel","year":"2016","unstructured":"McDaniel LS, Swiatlo E (2016) Should pneumococcal vaccines eliminate nasopharyngeal colonization? MBio 7:e00545-16","journal-title":"MBio"}],"updated-by":[{"DOI":"10.1007\/s10096-017-3107-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000}}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2834-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:31:19Z","timestamp":1498347079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2834-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2834-2","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s10096-017-3107-4","asserted-by":"object"}]},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}